Skincare Market Set for Dynamic Growth, USD 380,492.2 Million by 2034 at a 8.6% of CAGR

Skincare Market
Skincare Market

The global skincare market is poised for substantial growth, with an estimated market size of USD 166,870.4 million in 2024. According to the latest industry analysis, the market is expected to expand at a robust compound annual growth rate (CAGR) of 8.6% from 2024 to 2034.

By the end of the forecast period in 2034, the demand for skincare products is projected to surge to a remarkable valuation of USD 380,492.2 million. This growth trajectory underscores the increasing consumer focus on skincare and the rising popularity of advanced skincare solutions.

This significant growth is driven by increasing consumer awareness about skincare, rising demand for advanced and personalized skincare solutions, and the expansion of product offerings across various segments. The growing emphasis on maintaining healthy skin, coupled with innovations in skincare technology and formulations, is fueling the market’s upward trajectory.

The skincare market’s expansion reflects a broader trend toward enhanced personal care and wellness, with consumers increasingly seeking products that offer both aesthetic and health benefits. As skincare technology evolves and new trends emerge, the market is poised for continued growth and diversification.

Key Takeaways from Skincare Market Study :

  • Skincare market is expected to rise at 8.6% CAGR between 2024 to 2034
  • The U.K. will remain a key market for skincare products within Europe. Rising demand from various hospitals, healthcare, and critical care centers will continue supporting growth
  • Expansion of the healthcare sector will push growth in Germany, which will account for maximum skincare products sales within Europe’s healthcare sector
  • Strong growth is likely in China, as consumers increasingly focus on hygiene and sanitization to prevent the risk of infection

Competitive Analysis:

The market is characterized by a small number of startups and well-established skincare vendors. Companies have been expanding their product offerings and developing new markets by introducing cosmeceuticals and cutting-edge skin care products to appeal to a wider spectrum of consumers.

In an effort to take the lead in the skincare product market, the main competitors are exploring mergers and acquisitions. In order to solve customers’ persistent problems caused by the aging population and a lack of time for care, skincare producers are reinventing their products and creating sophisticated and specialty categories.

Prominent Skincare Product Manufacturers:

  • 3M Company
  • Cardinal Health, Inc.
  • Ecolab
  • Gojo Industries, Inc.
  • Beiersdorf AG’s NX NIVEA
  • Whiteley Corporation
  • Reckitt Benckiser Group PLC
  • Carroll Clean
  • Johnson & Johnson Consumer Inc.
  • Galderma laboratories, L.P.
  • PDI, Inc.
  • Betco Corporation
  • Pal International
  • PSK Pharma Pvt. Ltd.
  • Metrex Research, LLC.
  • Gojo Industries, Inc.
  • Unilever
  • Steris Plc.
  • Procter & Gamble

A Old Full Report Analysis Click Here

Key Segments:

By Product:

  • Skin Cleansers
  • Hand Sanitizers
  • Surgical Scrubs
  • Skin Care Cosmetics
  • Other

By Skin Type:

  • Normal
  • Dry
  • Oily

By Form:

  • Liquid Skincare
  • Gel and Lotions
  • Wipes
  • Spray and Foams

By End-user:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Reference Laboratories
  • Rehabilitation Centers
  • Long Term Care Centers
  • Critical Care Centers
  • Pharmaceutical and Biotechnology Companies
  • Academics and Research Institutes
  • Homecare Settings

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Asia Pacific
  • Middle East Asia

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Real-Time Bioprocess Raman Analyzer Market Poised for Growth, USD 33.7 Million by 2034 at a 4.8% of CAGR

Real-time Bioprocess Raman Analyzers Market
Real-time Bioprocess Raman Analyzers Market

The global  real-time bioprocess Raman analyzers market is on track to achieve significant growth, with sales expected to reach USD 21.1 million in 2024. According to recent industry analysis, the market is projected to evolve at a compound annual growth rate (CAGR) of 4.8% over the next decade.

By 2034, the real-time bioprocess Raman analyzer market is anticipated to attain a substantial valuation of USD 33.7 million. This growth is driven by the increasing adoption of advanced analytical technologies in bioprocess monitoring and optimization, highlighting the rising demand for precise, real-time data in biopharmaceutical manufacturing processes.

Real-time bioprocess Raman analyzers are becoming increasingly crucial in the life sciences and biotechnology sectors, providing critical insights for process monitoring and quality control in biomanufacturing. Their ability to offer real-time, non-invasive analysis enhances process efficiency and product quality, driving their growing adoption across various industries.

The market’s expansion is attributed to advancements in Raman spectroscopy technology, rising demand for efficient bioprocess monitoring solutions, and the increasing complexity of biopharmaceutical production processes. As companies seek to improve production accuracy and regulatory compliance, the role of real-time bioprocess Raman analyzers is expected to become more prominent.

Key Takeaways from Real-time bioprocess Raman Analyzers Market Study

  • The global Real-time bioprocess Raman Analyzers market is estimated to surpass US$ 8.7 Mn by 2021
  • The U,S, will emerge as dominant market in North America, accounting for over 95% of the overall sales
  • The U.K. will exhibit growth at a positive pace. According to FMI, it is expected to register nearly 20% Y-o-Y growth in 2021
  • Both Germany and France are expected to emerge as attractive markets for realtime bioprocess raman analyzer in Europe
  • Within East Asia, China will account for higher share of proceeds gained by the market
    “Increasing research and development activities are expected to boost the growth for Real-time bioprocess Raman Analyzers Market. On the other hand, there is a rising demand for quality healthcare and pharmaceuticals. This has been creating significant growth opportunities for key players” says the FMI Analyst  

Want more insights?

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global Real-time bioprocess Raman Analyzers market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the Real-time bioprocess Raman Analyzers market on basis of a component type (Raman Analysers, Raman Probes, and Software), applications (Lab to Process Analysis and Bioprocess Analysis), and end-users (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Research Organizations) across four major regions.

Who is Winning?

The global market is set to broaden its scope in the forecast period, driven by the increasing adoption rate of real-time and automated solutions during bioprocessing, advancements in technology, and reduced cost in manufacturing of biopharmaceuticals. However, lack of a skilled workforce and inadequate information about the benefits has constrained the sales of Real-time bioprocess Raman Analyzers.

Some of the key players operating in the market are Kaiser Optical Systems (Endress+Hauser), Resolution Spectra Systems Inc. (Merck KGaA), Tornado Spectral Systems, and Sartorius AG. Leading companies are consolidating their positions through mergers, acquisitions, and collaborations.

A Old Full Report Analysis Click Here

Real-time bioprocess Raman Analyzers Market by Category Component Type

  • Instruments
    • Raman Analyzers
    • Raman Probes
  • Software

Application

  • Lab to Process Analysis
  • Bioprocess Analysis

End User

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Research Organizations

Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Pharmaceutical Lipids Market Set for Robust Growth USD 8.04 Billion by 2033 at a 5.0% of CAGR

Pharmaceutical Lipids Market
Pharmaceutical Lipids Market

The global pharmaceutical lipids market is projected to experience steady growth, with an anticipated compound annual growth rate (CAGR) of 5.0% over the forecast period. The market is expected to achieve a revenue of approximately USD 4.93 billion in 2023 and is poised to surpass USD 8.04 billion by 2033.

This growth trajectory reflects the increasing demand for pharmaceutical lipids, driven by their essential role in drug formulation and delivery. Pharmaceutical lipids are crucial for the development of various therapeutic products, including those used in drug delivery systems, nutritional supplements, and advanced medical treatments.

Key factors contributing to the market’s expansion include advancements in lipid-based drug delivery technologies, growing investments in pharmaceutical research and development, and the rising prevalence of chronic diseases requiring innovative treatment solutions.

Furthermore, efforts by governments and regulatory agencies in developed nations, such as the U.S. and the U.K., to streamline the approval process for excipients, are expected to push sales in the market. Because of their cost-effectiveness and patient compliance, oral solid dosage forms are the dominant mode of delivery in the Global Pharmaceutical Lipids Industry and are the preferred option for many pharmaceutical products.

The use of capsules or tablets for drug delivery provides advantages such as increased physical and chemical stability, ease of handling, distinct brand recognition based on colour and shape, and controlled-release options. The majority of liposomal drugs are derived from oral solid drug formulations. The ease of use among patients, particularly children, is expected to boost sales of oral drugs, which will have a direct impact on pharmaceutical lipid sales.

For example, conventional hard solid tablets are difficult to swallow for approximately 50% of patients. This has prompted pharmaceutical companies to create more innovative solid oral product forms, such as effervescent tablets, orally disintegrating granules (ODGs), lozenges, chewable tablets, and instant drinks. This is expected to generate significant demand for liposomal excipients during the forecast period, boosting market growth.

 “Increasing investments in contract manufacturing of pharmaceutical lipids, along with growing demand for oral solid drug formulation is expected to augment the growth in the market over the forecast period,” says an FMI analyst. 

Key Takeaways:

  • Triglyceride sales are expected to account for more than 44.3% of the market by 2032, rising at a 5.1% CAGR during the forecast period.
  • By form, the semi-solid segment commands more than 60.0% of the market in 2021 and is expected to account for 62.7% of the total market share by 2032.
  • In terms of source, sales of semi-synthetic sources will increase at a 5.8% CAGR.
  • In 2021, applications in the conventional lipid-based drug delivery systems (LBDDS) segment held a commanding 64.4% share.
  • The most widely used route of administration will be oral pharmaceutical lipids. In 2021, the segment held 40.8% of the total market share.
  • The U.S. will continue dominating the North America pharmaceutical lipids market over the forecast period owing to the presence of a robust healthcare sector.
  • Demand in the U.K. pharmaceutical lipids market will surge at a 5.1% CAGR over the assessment period.
  • Sales in the India market are slated to increase at a 5.2% CAGR, accounting for a lion’s share in the South Asia pharmaceutical lipids market.

Competition Landscape 

Acquisitions, mergers, expansion, development of an extensive clinical pipeline and product launches are the key strategies adopted by manufacturers to increase the consumer base in various countries. For instance:

  • In July 2020, ABITEC announced the acquisition of Larodan AB, a manufacturer and international marketer of state-of-the-art, high-purity research grade lipids. The acquisition expanded ABITEC’s functional lipid product offerings and scientific capabilities to better serve the pharmaceutical, nutritional, and industrial markets.
  • In January 2020, BASF completed the acquisition of polyamide business of Solvay.
  • In July 2020, Croda International Plc announced the acquisition of Avanti Polar Lipids, Inc., a knowledge-intensive leader in lipid-based drug delivery technologies for the next generation of pharmaceuticals.

Key Companies Profiled

  • ABITEC Corporation (ABF Ingredients)
  • BASF SE
  • Croda International Plc
  • Corden Pharma
  • NOF (Nippon Oil & Fats) Corporation
  • Cayman Chemical Company
  • Lipoid GmbH

A Old Full Report Analysis Click Here

Key Market Segments Covered in Global Pharmaceutical Lipids Industry Research

By Product:

  • Triglycerides
  • Phospholipids
  • Sphingolipids
  • Cholesterol
  • Fatty Acids
  • Others

By Source:

  • Synthetic
  • Semi-synthetic
  • Natural

By Form:

  • Liquid
  • Semi-solid
  • Solid

By Application:

  • Conventional Lipid-based Drug Delivery Systems
  • Self-Emulsifying Drug Delivery Systems
  • Self-Microemulsifying Drug Delivery Systems
  • Liposomes
  • Solid Lipid Nanoparticles
  • Nanostructured Lipid Carriers
  • Others

By Route of Administration:

  • Oral
    • Tablet
    • Solution
  • Parenteral
    • Intravenous
    • Intramuscular (Vaccines)
  • Topical

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Compression Therapy Market Projected to Reach USD 5,925.20 Million by 2034 at a 5.80% of CAGR

Compression Therapy Market
Compression Therapy Market

The compression therapy market is experiencing notable expansion, with recent estimates forecasting revenue to reach approximately USD 3,371.70 million in 2024. Looking ahead, the market is expected to follow a promising growth trajectory, potentially attaining a valuation of USD 5,925.20 million by 2034. This represents a moderate compound annual growth rate (CAGR) of 5.80% over the assessment period.

Several key factors are driving this upward trend, including rising costs associated with sports injuries and automobile accidents, significant advancements in wound care technologies, and the growth of proactive treatments and rehabilitation programs. These elements are collectively fueling increased demand for compression therapy solutions, which play a critical role in managing and recovering from a variety of conditions.

The market’s expansion reflects a broader trend towards enhanced care and recovery options, supported by ongoing innovations and a growing emphasis on effective therapeutic solutions.

Key Takeaways from Compression Therapy Market Study

  • The static compression therapy held the largest market share in 2019 and the trend is expected to continue in the forecast period (2020-2030)
  • Chronic ulcers are expected to hold more than 69% of market share in terms of revenue in 2020
  • Among all distribution channel, institutional sales is the leading segment followed by retail sales. Retail sales segment is anticipated to grow at CAGR of 6% over the forecast period
  • North America and Europe are collectively expected to hold more than 67% of revenue share in 2020 while East Asia is expected to show greater growth potential in the forecast period.

“Acquisitions and launch of compression products along with increasing demand for compression therapy offering increased mobility, enhance athletic performance and safety profiles are driving the growth of global compression therapy market” says the FMI Analyst 

Expansion with Research: The Latest Trend

The compression therapy market players are onto the expansion spree to stand out.

For instance –

In May 2020, British Medical Journal published a study that stated that anti-embolism stockings are all the more effective with respect to DVT (deep vein thrombosis). This finding is bound to influence players to go for production of anti-embolism stockings in the forecast period

Avanos Medical Inc., in the year 2018, announced acquiring CoolSystems, Inc. The products post acquisition were marketed as “Game Ready”

Huntleigh Healthcare Ltd.’s IPC (Intermittent Pneumatic Compression) products under the “Hydroven” brand are a noteworthy addition to vascular assessment systems

Key Participant Insights

The global market is set to broaden its scope in the forecast period, stimulated by high prevalence rate of diabetes, rising geriatric population globally and adoption of advanced compression therapy systems which can be used as bi-layer and multi-layer for conventional treatment option. In addition to this, strict guidelines limits the design space for potential conceptual ideas and availability of alternate therapies has augmented the sales of compression products.

The key market players covered by FMI include:

  1. Paul Hartmann AG,
  2. Sigvaris AG,
  3. Cardinal Health Inc.
  4. 3M Health Care Ltd.

Compression Therapy Market Key Segment

Product Type

  • Pneumatic Compression Therapy
  • Non-Segmented Pneumatic Compression Pumps
  • Pneumatic Compression Sleeves
  • Lower Pneumatic Compression Sleeves
  • Upper Pneumatic Compression Sleeves
  • Segmented Pneumatic Compression Pumps
  • Segmented Pneumatic Compression Pumps with Calibrated Gradient
  • Segmented Pneumatic Compression Pumps without Gradient
  • Static Compression Therapy
  • Anti-Embolism Stockings
  • Compression Bandages
  • Compression Garments
  • Lower Compression Garments
  • Upper Compression Garments

A Old Full Report Analysis Click Here

Compression Therapy Market by Indication:

  • Chronic Ulcers
  • Venous Leg Ulcers
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Non-healing Surgical Wounds
  • Traumatic Wounds
  • Burn Cases

Compression Therapy Market by Distribution Channel:

  • Institutional Sales
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Nursing Facilities
  • Retail Sales
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

Compression Therapy Market by Region:

  • North America Compression Therapy Market
  • Latin America Compression Therapy Market
  • Europe Compression Therapy Market
  • East Asia Compression Therapy Market
  • South Asia & Pacific Compression Therapy Market
  • Middle East & Africa (MEA) Compression Therapy Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Orthopedic Braces and Support Market Projected to Reach USD 8.8 Billion by 2034, Growing at a CAGR of 6.7%

Orthopedic Braces and Support
Orthopedic Braces and Support

The global orthopedic braces and support market is set for significant growth, with projections indicating a rise from an estimated valuation of USD 4.6 billion in 2024 to approximately USD 8.8 billion by 2034. This growth trajectory reflects a robust compound annual growth rate (CAGR) of 6.7% over the assessment period.

The expanding market is driven by an increasing prevalence of musculoskeletal disorders, a rising aging population, and growing awareness of orthopedic health. Technological advancements in brace and support design, along with a growing focus on preventive care and rehabilitation, are further contributing to market expansion.

The orthopedic braces and support market encompasses a wide range of products designed to assist in the treatment and management of various orthopedic conditions, enhancing mobility and providing support for individuals recovering from injuries or surgeries.

The healthcare industry is embracing technological intervention with digital health, virtual health, and telehealth to treat patients.

Such trends are emerging as a potential disruptor in the orthopedic braces and support market, which has been facing the brunt of the COVID-19 pandemic.

Key Takeaways :

  • Rising Incidence of Orthopedic Disorders: The prevalence of orthopedic conditions such as osteoarthritis, osteoporosis, and sports injuries is increasing globally, leading to a growing demand for orthopedic braces and support products.
  • Increasing Awareness and Adoption: There is a growing awareness among patients and healthcare professionals about the benefits of using orthopedic braces and supports for rehabilitation, injury prevention, and pain management, driving the adoption of these products.
  • Technological Advancements: Advances in materials science and manufacturing technologies are enabling the development of lightweight, ergonomic, and customizable orthopedic braces and support solutions, enhancing patient comfort and compliance.

As the global population continues to age and lifestyles become increasingly sedentary, the demand for orthopedic braces and support products is expected to witness sustained growth in the coming years.

Top Recommended Strategies to Stay Ahead of Market Competition:

  • Key players can use smart sensors, materials, and biofeedback mechanisms to provide rehabilitation experiences and personalized support for effective rehabilitation bracing solutions.
  • Companies need to prioritize research to develop new materials, applications, and designs for braces and support to effectively meet the needs of patients and align with emerging trends.
  • Industry participants can consider collaborating with experts to prepare products validated for science and practical use cases.
  • Market contenders can offer customization options like personalized support levels and custom-fit braces to meet individual needs effectively.
  • By focusing on streamlining the purchase process, like offering hassle-free returns and convenient online ordering options, players can build loyalty and trust among their target market.

Recent Developments

  • In October 2023, OrthoPediatrics Corp. launched the DF2 Brace as a strategy to expand into non-surgical business to treat kids suffering from musculoskeletal injuries.
  • In September 2023, Enovis Corporation officially disclosed the acquisition of LimaCorporate S.p.A. The acquisition of the latter company added a wide variety of orthopedic medical devices like braces and other support apparatus.

Key Players in the Orthopedic Braces and Support Industry:

  • DJO, LLC (United States)
  • Zimmer Biomet (United States
  • Medtronic (Ireland)
  • Stryker Corporation (United States)
  • Össur (Iceland)
  • NuVasive®, Inc (United States)
  • Integra LifeSciences Corporation (United States)
  • Globus Medical (United States)
  • OTTOBOCK (Germany)
  • AC Mould Engineering Limited (China)
  • Johnson and Johnson Services, Inc (United States)
  • Weber Orthopedic LP. DBA Hely and Webe (United States)
  • BSN medical (India)
  • Becker Orthopedic (United States)
  • OPPO MEDICAL INC (United States)
  • Langer Biomechanics (United States)
  • Frank Stubbs Company Inc. (United States)
  • DeRoyal Industries, Inc (United States)
  • Ascent Meditech Limited (India)
  • Alcare Co., Ltd (Tokyo)
  • Others

Orthopedic Braces and Support Industry by Category:

By Product:

  • Braces and Supports Type
    • Knee Braces for Osteoarthritis and Ligament Injuries
    • Post-operational Knee Braces
    • Upper Spine Orthoses
    • TLSOs
    • LSOs
    • Soft Braces
    • Hinged Braces
    • Pneumatic
    • Non-pneumatic
    • Elbow Braces and Supports
    • Wrist Braces and Supports
  • Pain Management Products
    • Cold Therapy Products
    • DVT Products

By End-user:

  • Orthopedic Clinics
  • Over the Counter (OTC)
  • Hospitals
  • DME Dealers
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and the Pacific
  • East Asia
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Automated Cell Culture Systems Market Expected to Reach USD 20.87 Billion by 2030

Automated Cell Culture Systems Market
Automated Cell Culture Systems Market

The automated cell culture systems market is on track for significant expansion, with projections indicating a substantial increase from an estimated valuation of USD 10.91 billion in 2022 to approximately USD 20.87 billion by 2030. This growth is expected to occur at a robust compound annual growth rate (CAGR) of 8.4%.

Automated cell culture systems currently hold a substantial 44.5% share of the global cell culture market, reflecting their pivotal role in advancing biological research and pharmaceutical development. The expansion of this market is being driven by several key factors, including rising investment in stem cell research and development, recent drug breakthroughs, and increased funding towards the development of innovative cell culture technologies.

The surge in demand for automated systems is attributed to their ability to enhance efficiency, reproducibility, and scalability in cell culture processes. These advancements are critical for accelerating research and development efforts, particularly in the fields of drug discovery and regenerative medicine.

Besides, 3D cell cultures, which were cumbersome and costly earlier, have become feasible, owing to advent of spheroids. Also, they imitate tumors better due to hypoxic core and presence of nutrient gradient.

Researchers in the US and Germany have come up with a protocol to grow 3D cultures of generally used cancer cells to facilitate drug screenings. These factors will continue to put North America and Europe at the top pedestal in the automated cell culture systems market.

Further, the requirement of cell lines for devising vaccines against COVID-19 infection will augur well for the automated cell culture market despite the pandemic-induced economic downturn.

Automated Cell Culture Systems Market Outlook & Key Findings

  • Automated cell culture systems market is expected to witness a CAGR of 8% through 2030
  • Growing applications of cell lines in drug discovery to be a key growth driver
  • Consumables hold more than 60% of market value owing to ever-increasing research in stem cells and oncology
  • North America to capture more than 40% of market value and is expected to witness a CAGR of 6% through 2030
  • Biotech companies  to remain prominent end users throughout the forecast period

Key Takeaways from the Automated Cell Culture Systems Market

  • Consumables are expected to reach US$ 11 Bn by 2030
  • Academic institutes are expected to take greater interest in research related to cell culture over the forecast period due to increased government funding in developed countries
  • North America and Europe collectively accounted for more than 60% of market share in 2019
  • Infinite cell line cultures held close to 75% of market share in 2019

“Advancements in technology, coupled with large-scale applications in cell-based drug delivery and drug discovery, are projected to drive the global automated cell culture systems market” – says the FMI analyst.

A Old Full Report Analysis Click Here

Key Segments of Automated Cell Culture Systems Industry Survey

Automated Cell Culture Systems Market by Product:

  • Automated Cell Culture Storage Equipment
  • Automated Cell Culture Vessels
  • Bioreactors
  • Consumables

Automated Cell Culture Systems Market by Cell Culture:

  • Finite Cell Line Cultures
  • Infinite Cell Line Cultures

Automated Cell Culture Systems Market by Application:

  • Drug Development
  • Stem Cell Research
  • Regenerative Medicine
  • Cancer Research

Automated Cell Culture Systems Market by End User:

  • Biotech Companies
  • Research Organizations
  • Academic Institutes

Automated Cell Culture Systems Market by Region:

  • North America Automated Cell Culture Systems Market
  • Latin America Automated Cell Culture Systems Market
  • Europe Automated Cell Culture Systems Market
  • East Asia Automated Cell Culture Systems Market
  • South Asia & Pacific Automated Cell Culture Systems Market
  • Middle East & Africa (MEA) Automated Cell Culture Systems Market

Automated Cell Culture Systems Market: Competitive Insights

The global automated cell culture systems market is set to expand its scope in the forecast period, stimulated by increasing drug discovery research and diverse applications of cell lines in research purposes. Furthermore, automated cell culture systems are used for experiments in drug discovery research and in cell banking process. In addition, cost effectiveness and rise in alternative methods for traditional cell culture production is augmenting the adoption of automated cell culture systems.

Key market players covered in the market include Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Tecan Trading AG, Hamilton Medical AG., Biospherix and Promocell GmbH.  Key players integrate their positions through acquisitions, mergers and new product launches.

Want more insights?

The study provides compelling insights on automated cell culture systems market on basis of product type (automated cell culture storage equipment, automated cell culture vessels, bioreactors and consumables), cell culture type (finite cell line cultures, infinite cell line cultures), application (drug development, stem cell research, regenerative medicine and cancer research) and end user (biotech companies, research organizations, academic institutes), and across seven major regions.

Author by

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Oligonucleotide API Market Projected to Reach USD 4.84 Billion by 2034 at a 5.60% of CAGR

Oligonucleotide API Market
Oligonucleotide API Market

The global oligonucleotide API market is poised for substantial growth, driven by increasing demand for new drug classes. According to recent projections, the market is expected to rise at a robust compound annual growth rate (CAGR) of 5.60% from 2024 to 2034. The market, valued at approximately USD 2.81 billion in 2024, is forecasted to expand to USD 4.84 billion by the end of 2034.

This anticipated growth is fueled by the growing need for advanced therapeutic options and the development of innovative drug classes that utilize oligonucleotide APIs. The surge in research and development activities, coupled with the rising prevalence of genetic and chronic diseases, is expected to drive demand for these specialized APIs.

The market’s expansion underscores the increasing importance of oligonucleotide APIs in drug development and their pivotal role in advancing personalized medicine. As the industry evolves, stakeholders, pharmaceutical companies, and investors are presented with significant opportunities in this dynamic sector.

Apart from immune therapy, microbial and cardiovascular infections, and cancer, oligonucleotide APIs are being tried out to treat neurological disorders like Alzheimer’s as well. However, factors like regulatory complexities and timely delivery of oligonucleotides (amidst COVID-19) are acting as restraints.

Key Takeaways from Global Oligonucleotide API Industry Study

  • Antisense oligonucleotide APIs are anticipated to reach US$ 4 Bn by 2030.
  • North America and Europe collectively accounted for more than 47% of revenue share in 2019 while Asia Pacific is expected to grow at the fastest rate in the forecast period.
  • Increase in the use of antisense oligonucleotide APIs (especially post-approval from the US FDA in 2016) to boost the market in the forecast period

 “Inorganic mode of growth coupled with broad therapeutic applications in gene therapy is expected to bolster the Global Oligonucleotide API Industry,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

New Product Launches: Key Indicators to Global Oligonucleotide API Industry

FMI has analyzed players such as Akcea Therapeutics, Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., and Dynavax Technologies in this report. According to the analysis, these players are consolidating their positions through new product launches.

For instance –

  • In March 2020, Dynavax entered into a collaboration with Clover Biopharmaceuticals to develop a vaccine candidate to combat COVID-19. Clover is into advanced evaluation of its Covid-19 S-Trimer, protein-based coronavirus vaccine candidate and Dynavax has its technical expertise along with proprietary toll-like receptor 9 (TLR9) agonist adjuvant, CpG 1018 for executing this.
  • Alnylam Pharmaceuticals, Inc., in 2018, launched Givlaari and Onpattro at the commercial level.

Gene Therapy and Oligonucleotide APIs

Synthetic oligonucleotides are being used in gene therapy for inactivating genes that help in propagating the disease. Antisense oligonucleotide APIs are used for disrupting the faulty gene’s transcription.

Also, siRNA could be used for signaling the cell to disrupt faulty mRNA’s translation. Along these lines, Pharmamar, in Jan 2020, signed an agreement with Jazz Pharmaceuticals to sell the API for “lurbinectedin”, one of the late-phase treatments for SCLC (small cell lung cancer) so that the latter could commercialize it.

A Old Full Report Analysis Click Here

Key Segments of Oligonucleotide API Industry Survey: 

Global Oligonucleotide API Industry by API:

  • Antisense Oligonucleotides APIs
  • Short Interfering RNA (siRNA) APIs
  • Phosphorodiamidate Morpholino Oligonucleotides (PMO) APIs
  • MiRNA APIs
  • Aptamers APIs
  • CpG Oligonucleotides APIs
  • Others (ON Conjugates (NP), ShRNA, etc.)

Global Oligonucleotide API Industry by Marketing Status:

  • Marketed
  • Clinical Trials (Clinical Phases)

Global Oligonucleotide API Industry by End User:

  • Contract Manufacturing Organizations (CMOs)
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Development & Manufacturing Organizations (CDMOs)

Global Oligonucleotide API Industry by Region:

  • North America Oligonucleotide API Market
  • Latin America Oligonucleotide API Market
  • Europe Oligonucleotide API Market
  • East Asia Oligonucleotide API Market
  • South Asia & Pacific Oligonucleotide API Market
  • Middle East & Africa (MEA) Oligonucleotide API Market

Key Companies Profiled:

  • Jazz Pharmaceuticals, Inc.
  • Sarepta Therapeutics
  • Biogen
  • Dynavax Technologies
  • Akcea Therapeutics.
  • Alnylam Pharmaceuticals, Inc.

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Injectable Benzodiazepine Market Set to Achieve USD 356 Million by 2032 with a Noteworthy 2.7% CAGR | FMI

Injectable Benzodiazepine Market
Injectable Benzodiazepine Market

The Global Injectable Benzodiazepine Industry are predicted to reach USD 274 million by the end of 2022. Sales of injectable benzodiazepines are predicted to reach USD 356 million by 2032’s end. From 2022 to 2032, the injectable benzodiazepines market is anticipated to expand at a 2.7% CAGR.

Global Injectable Benzodiazepine Industry sales are set to reach USD 260 million in 2020, as COVID-19 panic and uncertainty have set in, even among populations with no previous history of mental illnesses, according to a new study by Future Market Insights (FMI). The market research firm estimates the market to grow at 2.7% CAGR through 2030.

Although COVID-19 will create a short-term spike, in the long run, the market is likely to be driven by increasing demand for generic drugs. Growing acceptance of injectables as a route of administration is also likely to drive growth.

Key Takeaways of Global Injectable Benzodiazepine Industry Study

  • Lorazepam injectable benzodiazepine accounted for the highest share in the injectable benzodiazepine market in 2019
  • Seizures and anxiety are among the leading ailments where injectable benzodiazepines are administered
  • North America and Europe are expected to hold a noteworthy revenue share of about 60% in the Global Injectable Benzodiazepine Industry in 2020

Low-cost manufacturing and large patient pools in Asian countries are expected to be a key growth driver in the forecast period

“Growing incidences of seizures and anxiety followed by demand for generics to boost the Global Injectable Benzodiazepine Industry,” says an FMI Analyst.

Research Collaborations: Key to Sustenance

The market players are emphasizing expanding their manufacturing facilities with the introduction of cost-effective and generic drugs and also venturing into strategic partnerships.

  • In Jan 2020, Hospital Sales Force from Xellia signed an agreement with Eton to promote Biorphen in institutions that prefer having ready-to-use injectable formulations
  • In Oct 2019, KemPharm’s APADAZ (to treat ADHD) got licensed to KVK-Tech, Inc. to make its generic AG-APADAZ available all across the US
  • In Dec 2018, Hikma Pharmaceuticals came up with clobazam oral suspension as well as tablets, the generic equivalent to “Onfi” (marketed by H. Lundbeck A/S)

What else is in the report?

Future market insights offer a unique perspective and actionable insights on the Global Injectable Benzodiazepine Industry in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on drug class (diazepam, lorazepam, and midazolam), by the time of action (short-acting long-acting), by indication (agitation & aggression, anxiety, alcohol withdrawal, muscle spasm, seizures, tetanus, sedation, anesthesia insomnia, and status epilepticus), by distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies) in seven key regions.

A Old Full Report Analysis Click Here

Key Segments of the Global Injectable Benzodiazepine Industry

FMI’s study on the injectable benzodiazepines market offers information divided into three important segments— drug class, indication, time of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Class

  • Diazepam
  • Lorazepam
  • Midazolam

Time of Action

  • Short Acting
  • Long Acting

Indication

  • Agitation & Aggression
  • Anxiety
  • Alcohol Withdrawal
  • Muscle Spasm
  • Seizures
  • Tetanus
  • Sedation
  • Anesthesia
  • Insomnia
  • Status Epilepticus

Distribution Channel

  • Hospital
  • Ambulatory Surgical centers
  • Diagnostics Centers

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Guidewires Market Set to Reach USD 5.9 Billion by 2030 at a 6.1% of CAGR

Global Guidewires Market
Global Guidewires Market

The global guidewires market is on track for substantial growth, according to recent analysis. The market is estimated to have reached a value of approximately USD 3.7 billion in 2022 and is forecasted to experience a robust compound annual growth rate (CAGR) of 6.1% from 2022 to 2030.

This anticipated growth reflects a rising demand for guidewires, driven by advancements in medical technology, an increase in minimally invasive procedures, and a growing prevalence of chronic diseases that require advanced diagnostic and therapeutic interventions. The expansion of healthcare infrastructure and innovations in guidewire design and materials are also contributing to the market’s positive outlook.

The guidewires market is positioned to benefit from ongoing improvements in medical devices and techniques, making it a key area of interest for stakeholders, investors, and industry professionals.

The WHO Global NCD Action Plan 2015-2021 does follow on with recognition of primary role as well as responsibility of various governments regarding responding positively to challenge posed by NCDs and international co-operation for supporting national efforts.

A part of their action plan is bringing down all the NCDs listed above by at least 30% and render 80% availability of basic technologies/medications.

These include provision of guidewires to facilitate minimally-invasive surgical procedures at affordable rates in ambulatory centres. These factors have been collectively driving the guidewires market till date and will continue to do so in the forecast period as well.

Plus, US FDA has come up with guidelines regarding upgradation of guidewires to ensure faster and more efficient procedures. This is another factor giving impetus to the market. This upgradation is likely to happen through inorganic as well as organic mode of expansion.

Again, as per FMI, the global guidewires market is slated to value US$ 3.3 Bn in 2022 and expected to witness a substantial CAGR of over 6.0% between 2022 and 2030.

Key Takeaways of Guidewires Market Study

  • The global guidewires market, in the year 2021, was dominated by interventional guidewires as they continue to be the first choice with regards to minimally-invasive surgical procedures
  • As far as applications are concerned, peripheral and coronary guidewires collectively account for around 65% of revenue share
  • By material, stainless steel, due to superior torque and ductility, is expected to be the highest revenue generator in the forecast period.
  • North America is expected to be the most lucrative region and expected to generate around 40% of the overall revenue in 2022 and this trend is expected to continue during the forecast period.

“Technological advancements such as the development of multifunctional and low-cost guidewires are expected to provide an innovative paradigm shift to market players.” Says the FMI Analyst.

New Product Launches – The Win-Win Strategy for Market Players

The market players are focusing on launching advanced products for supporting clinicians with respect to interventional or diagnostic procedures. For instance – Olympus Corporation, in May 2021, tabled RevoWave endoscopic guidewire in the U.S. for performing balloon dilation, biliary endoscopy, and stent placement.

On the similar grounds, Abbott’s Frontline Workhorse guidewires are making ways for most interventional devices.

What else is in the report?

Future Market Insights offers actionable insights and unique perspective on guidewires market in its latest study, presenting historical demand assessment from 2015 – 2021 and projections from 2022–2030 based on product type (interventional guidewires and diagnostic guidewires), by application (coronary guidewires, peripheral guidewires, urology guidewires, radiology guidewires, neurovascular guidewires, gastroenterology guidewires and others) by material type (Nitinol guidewires, PTFE guidewires, stainless steel guidewires and hybrid guidewires) by tip shape (J tip, angled tip and straight tip) by end-user (hospitals, ambulatory surgical centres, cardiac catheterization laboratories and speciality clinics) in seven key regions.

A Old Full Report Analysis Click Here

Key Market Segments Covered In Guidewires Industry ResearchBy Product :

  • Interventional Guidewires
    • Hydrophilic Guidewires
    • Hydrophobic Guidewires
  • Diagnostic Guidewires
    • Hydrophilic Guidewires
    • Hydrophobic Guidewires

By Application :

  • Coronary Guidewires
  • Peripheral Guidewires
  • Urology Guidewires
  • Radiology Guidewires
  • Neurovascular Guidewires
  • Gastroenterology Guidewires
  • Others

By Material Type :

  • Nitinol Guidewires
  • PTFE Guidewires
  • Stainless Steel Guidewires
  • Hybrid Guidewires

By Tip Shape :

  • J Tip
  • Angled Tip
  • Straight Tip

By End User :

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
  • Specialty Clinics

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Swab and Viral Transport Medium Market Expected to Reach USD 15.60 Billion by 2033 at a 5.8% of CAGR

Swab and Viral Transport Medium Market
Swab and Viral Transport Medium Industry

Future Market Insights (FMI) has released a new analysis revealing promising growth for the global swab and viral transport medium market. According to FMI’s market attractiveness analysis, the global market is projected to reach approximately USD 8.86 billion by the end of 2023. The market is anticipated to grow at a robust compound annual growth rate (CAGR) of 5.8%, surpassing USD 15.60 billion by 2033.

This significant growth trajectory underscores the increasing demand for swab and viral transport mediums, driven by their crucial role in diagnostic testing and disease management. The rise in global health initiatives, heightened awareness of infectious diseases, and advancements in diagnostic technologies are key factors contributing to this market expansion.

The analysis highlights the evolving needs of healthcare providers and the growing emphasis on accurate and efficient testing processes. As the market evolves, stakeholders and industry players are presented with substantial opportunities for growth and innovation.

Companies in the swab and viral transport medium business are producing inventive kits with vials, double-ended flocked swabs, medications, and other items that avoid bacterial or fungal contamination. They are concentrating on a better solution formulation to stop the growth of bacterial and fungal flora. The market is expanding owing to new viral transport medium solutions.

An additional element fueling the market expansion is the rise in the number of novel viruses that have the potential to infect humans and cause a variety of illnesses. According to an article in Nature from 2021, certain respiratory viruses are resurfacing in unexpected ways as pandemic limitations loosen. Infections with the respiratory syncytial virus (RSV), which accounts for 5% of all pediatric fatalities globally, began to rise in April 2021. As a result of the increased need for specimen collection kits and diagnosis, the prevalence of additional infectious illnesses is predicted to propel market expansion.

Manufacturers are creating viral transport mediums for influenza diagnostics as the flu season gets underway. Healthcare in western nations is extremely concerned about influenza-related morbidity and death. To provide swabs and viral transport mediums, manufacturers are expanding their research and development capabilities. Manufacturers are also starting to recognize the advantages of online pharmacies over hospitals and retail pharmacies. To increase their revenue sources, they are working with established e-Commerce companies.

Owing to its highly developed medical infrastructure and high frequency of infectious illnesses, North America is predicted to dominate the global market during the forecast period. During the pandemic, North America saw a spike in laboratory testing, which fueled the market expansion. The market is also growing significantly due to the existence of biopharma businesses, a large number of labs, and research studies on viral infection.

Key Takeaways

  • The market in the United Kingdom is anticipated to rise, exhibiting a CAGR of 9%through 2033.
  • The United States is expected to develop at a1%CAGR during the forecast period.
  • With a CAGR of 0%over the forecast period, Canada is predicted to develop promptly in the market.
  • In China, the market is expected to proliferate, registering a CAGR of 7%over the forecast period.
  • Germany is estimated to grow decently registering a CAGR of 7% until 2033.

Competitive Landscape

Top players operating in the swab and viral transport medium market are McKesson Corporation, Cardinal Health Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Quidel Corporation, COPAN Diagnostics Inc., VIRCELL S.L., Deltalab, Titan Biotech Ltd., Medical Wire & Equipment, and others.

These market players are always inventing and creating new products to suit the various requirements of diagnostic laboratories and research institutions. They are enhancing the design and components used in swabs to enhance their collection efficacy. They are also developing transport mediums that can hold viral specimens for extended periods without compromising their vitality. Additionally, to improve the stability and accuracy of diagnostic samples, they are also combining advanced technologies.

Recent Developments

  • In June 2022, the start of long-distance drone deliveries in North Carolina was announced by Zipline and Cardinal Health.
  • In May 2020, in several pharmacies across the United States, Health Mart® pharmacies announced that they would provide free COVID-19 test collection. Health Mart is dedicated to creating cutting-edge public and private collaborations as a member of the McKesson Corporation to assist address the COVID-19 epidemic.

Other Key Players Operating in the Swab and Viral Transport Market

  • Thermo Fisher Scientific Inc.,
  • Quidel Corporation,
  • COPAN Diagnostics Inc.,
  • VIRCELL S.L., Deltalab,
  • Titan Biotech Ltd.,
  • Medical Wire & Equipment

Swab and Viral Transport Medium Market by Category

By Product:

  • Viral Transport Medium
    • Tissue Culture Medium
    • Glycerol Transport Medium
  • Virus Swabs
    • Nasopharyngeal Swabs
    • Deep Nasal Swabs
    • Combined Nasal & Throat Swabs
    • Culture Swabs
    • Vaginal Swabs

By Application:

  • Influenza
  • Respiratory syncytial virus
  • Mumps Virus
  • Adenovirus
  • Rhinovirus
  • Herpes Simplex Virus
  • Varicella-Zoster Virus
  • Other Indication

By End User:

  • Hospitals & ASCs
  • Specialty Clinics
  • Diagnostic Laboratories
  • Others

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube